A critical advance in cancer research is arising with the use of nanobodies to re-engage damaged p53. This essential cancer protector protein is frequently disabled in various types of cancer, causing uncontrolled https://friendlybookmark.com/story21819139/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-treatment